Short answer
The Raleigh-Cary metro had 10 pharmaceutical manufacturing establishments in 2023 with 5,429 employees, an average of 543 per site and $104,425 average pay (Census County Business Patterns). Wake County had 8 of them; the rest are in Johnston County, where FDA's registration file lists Novo Nordisk and Grifols plants in Clayton. Other registered sites include FUJIFILM and Seqirus in Holly Springs and GSK in Zebulon. Liquidia and TG Therapeutics give Morrisville headquarters addresses.
- At 543 employees per establishment, Raleigh's drug plants are about five times the size of Boston's.
- Novo Nordisk says its Clayton site employs more than 2,000 and is getting a $4.1 billion expansion.
- Amgen's 10-K says its Holly Springs drug substance plant opened in January 2025 and awaits FDA approval.
- Durham-Chapel Hill, a separate Census metro, has 16 plants and 100 biotech R&D establishments.
- Morrisville has 17 FDA-registered drug sites, more than Raleigh itself (10).
On this page
This report is for people looking for drug companies around Raleigh: technicians and engineers looking for plant jobs, suppliers and contract partners, and sellers covering the Triangle. The Census Bureau's Raleigh-Cary metro is Wake, Johnston and Franklin counties. Research Triangle Park is mostly in Durham County, which the Census Bureau puts in a different metro, so both appear below.
Ten establishments, 5,429 jobs
County Business Patterns (CBP) 2023, NAICS 3254 (Pharmaceutical and Medicine Manufacturing), Raleigh-Cary, NC Metro Area (CBSA 39580):
| Measure (2023) | Raleigh metro |
|---|---|
| Establishments | 10 |
| Employees | 5,429 |
| Annual payroll | $566,922,000 |
| Average employees per establishment | 542.9 |
| Average annual pay | $104,425 |
| Share of US establishments | 0.34% of 2,901 |
Three of the 10 have 1 to 4 employees; the Census Bureau doesn't publish the other size classes for so few sites. That leaves 7 establishments holding nearly all 5,429 jobs.
Wake County had 8 establishments and 1,958 employees. Johnston and Franklin counties have no published row, because the Census Bureau publishes a cell only when it holds three or more establishments. Subtracting Wake from the metro total leaves 2 establishments with about 3,471 employees outside Wake (our subtraction; both totals carry some noise). By product, 5 establishments make finished-dose pharmaceuticals (325412, 2,600 employees) and 4 make biological products such as vaccines and plasma proteins (325414; the employee total is not reported, a high-noise figure, meaning the Census Bureau's confidentiality noise moved it by 5% or more).
The count is of establishments with paid staff, not of companies, and excludes the self-employed. Code 3254 counts manufacturing only: head offices, research labs and distribution centers are classed in other industries, so a company's Raleigh office won't appear here even if it runs a plant elsewhere.
Two metros share the Triangle
| CBP 2023 | Raleigh-Cary metro | Durham-Chapel Hill metro |
|---|---|---|
| Drug manufacturing establishments (3254) | 10 | 16 |
| Drug manufacturing employees | 5,429 | 4,071 |
| Biotechnology R&D establishments (541714) | 86 | 100 |
| Biotechnology R&D employees | 1,845 | 4,368 |
| Drug wholesale establishments (424210) | 63 | 20 |
Raleigh's side is heavier on large plants and distribution; Durham's on research. A job search or territory plan that stops at the Wake County line misses half the Triangle. For the statewide view, see the North Carolina pharmaceutical market report.
The sites, town by town
Every site that makes, packs or tests drugs for the US market registers with FDA, which publishes the list as the Drug Establishments Current Registration Site (DECRS). Counting the 30 October 2026 download for Wake, Johnston and Franklin counties, we found 40 registrations: 22 that make finished drugs or active ingredients, 5 medical gas suppliers (our classification by firm name), 9 testing labs, 3 packers or relabelers and 1 medicated feed mill. We placed each site by its ZIP code; Morrisville's ZIP codes cross into Durham County, so a few of its sites may sit on the Durham side.
| Town | Registered manufacturers (FDA file) |
|---|---|
| Clayton | Novo Nordisk Pharmaceutical Industries (ingredients and finished product), Grifols Therapeutics |
| Holly Springs | FUJIFILM Diosynth Biotechnologies North Carolina, Seqirus |
| Zebulon | GlaxoSmithKline |
| Raleigh | Indivior Manufacturing, Liebel-Flarsheim, SpecGx, Ajinomoto Health & Nutrition |
| Morrisville | Biogen (two sites), Catalent, Alcami (three sites), Liquidia Technologies, Chrysalis Raleigh |
| Cary and Garner | Sterling Pharma (ingredients), Avior, Alcami |
Morrisville also has the testing labs: BioAgilytix, Pace Analytical Life Sciences, Solvias and a United Therapeutics lab. Being registered doesn't mean FDA has approved a site or its products.
Expansions on the record
- Novo Nordisk. The company says Clayton is its first and largest US manufacturing presence, with more than 2,000 employees and nearly $6 billion invested, and that a $4.1 billion facility announced in 2024 will add 1,000 jobs.
- Amgen. Its 2025 10-K says the Holly Springs drug substance facility opened in January 2025 and will add biologics capacity once FDA approves it. It doesn't yet appear in FDA's registration file.
- Gilead. Its 10-K lists Raleigh among its administrative facilities.
Listed companies with Raleigh-area headquarters
| Company | Headquarters (10-K cover) | Revenue, 2025 | Employees reported |
|---|---|---|---|
| TG Therapeutics | 3020 Carrington Mill Blvd, Morrisville | $616.3 million | 399 (20 February 2026) |
| Liquidia | 419 Davis Drive, Morrisville | $158.3 million | 216 |
EDGAR still files TG Therapeutics under New York; its 10-K cover gives Morrisville. The only drug company EDGAR places in the Raleigh metro, Vogenx of Raleigh, hasn't filed an annual report yet. BioCryst, the state's largest listed drugmaker by revenue ($874.8 million in 2025), is in Durham. The global companies with plants here (Novo Nordisk, Grifols, GSK, FUJIFILM, Seqirus) report from overseas, so look them up in the largest pharmaceutical companies.
Getting into the industry
- Training. North Carolina's Commerce Department describes BioWork, a course developed in 2001 by the NC Biotechnology Center and the community college system for process technician jobs, and the Golden LEAF Biomanufacturing Training and Education Center (BTEC) at NC State, which runs training and a cGMP pilot plant.
- Maps. Wake County Economic Development publishes a life sciences map and brochure.
- The network. NCLifeSci, the state's life sciences trade association, keeps a member directory and an events calendar.
- Licences. FDA lists the North Carolina Department of Agriculture and Consumer Services as the agency that licenses wholesale drug distributors. Check any distributor or logistics partner there, and read FDA's Data Dashboard for a site's inspections and recalls.
Selling to Triangle plants
At a 500 to 2,000 person plant, buying is split: a site procurement team runs the contract, but engineering, quality or manufacturing operations picks the vendor. Clinical-stage companies in Morrisville buy through one operations leader.
Worked example: a cleanroom garment service
Illustrative example. The firm and its prices are invented; the counts come from CBP 2023 and FDA's registration file.
Neuse Cleanroom Services (neusecleanroom.example) launders and sterilizes cleanroom garments.
- List the sites. 22 registered manufacturers in the metro, plus the 16 Durham-Chapel Hill plants a van can reach the same day.
- Rank them. Sterile and biologics sites (Clayton, Holly Springs, the Biogen and FUJIFILM sites) use the most garments per worker.
- Do the arithmetic. A plant with 250 gowned staff, each using two garment sets a shift over five shifts a week, goes through 2,500 garments a week. Winning 2 such sites at $1.10 a garment brings 2 x 2,500 x $1.10 x 52 weeks = $286,000 a year.
Spotting which sites are adding a line is the slow part; Bebop researches each account and flags expansions and new hires.
Next step: compare the whole state's plant base in the North Carolina pharmaceutical market report.
Sources
- County Business Patterns (CBP), 2023, US Census Bureau, accessed 30 October 2026
- 2023 County Business Patterns datasets (metro and county files, NAICS 3254, 424210 and 541714), US Census Bureau, accessed 30 October 2026
- County Business Patterns methodology (publication rule and noise flags), US Census Bureau, accessed 30 October 2026
- Drug Establishments Current Registration Site (DECRS), US Food and Drug Administration, accessed 30 October 2026
- DECRS annual registration status download (drls_reg.zip), US Food and Drug Administration, accessed 30 October 2026
- North Carolina's Research Triangle Region, Novo Nordisk Inc., accessed 30 October 2026
- Amgen Inc. Form 10-K for 2025 (manufacturing), Amgen Inc., via SEC EDGAR, filed 13 February 2026
- Gilead Sciences Form 10-K for 2025 (Item 2, Properties), Gilead Sciences, Inc., via SEC EDGAR, filed 24 February 2026
- TG Therapeutics Form 10-K for 2025, TG Therapeutics, Inc., via SEC EDGAR, filed 27 February 2026
- Liquidia Corporation Form 10-K for 2025, Liquidia Corporation, via SEC EDGAR, filed 5 March 2026
- BioCryst Pharmaceuticals Form 10-K for 2025, BioCryst Pharmaceuticals, Inc., via SEC EDGAR, filed 26 February 2026
- Biotechnology and pharmaceuticals in North Carolina, North Carolina Department of Commerce, accessed 30 October 2026
- Life sciences, Wake County Economic Development, accessed 30 October 2026
- NCLifeSci, North Carolina Life Sciences Organization, NCLifeSci, accessed 30 October 2026
- Check licensure of wholesale drug distributors and third-party logistics providers, US Food and Drug Administration, accessed 30 October 2026
- FDA Data Dashboard, US Food and Drug Administration, accessed 30 October 2026
Written by the Bebop team at Blackpearl Group. Published .
Questions people ask
How many pharmaceutical companies are in Raleigh?
Census County Business Patterns counted 10 pharmaceutical manufacturing establishments in the Raleigh-Cary metro in 2023, with 5,429 employees. FDA's drug registration file lists 40 registered drug sites in Wake, Johnston and Franklin counties, because it also counts testing labs, packagers and gas suppliers. The neighboring Durham-Chapel Hill metro, which includes most of Research Triangle Park, had 16 more plants.
What pharmaceutical companies have plants near Raleigh?
FDA's registration file lists Novo Nordisk and Grifols in Clayton, FUJIFILM Diosynth and Seqirus in Holly Springs, GlaxoSmithKline in Zebulon, Indivior and SpecGx in Raleigh, and Biogen, Catalent and Alcami in Morrisville. Amgen's 2025 10-K says it opened a drug substance facility in Holly Springs in January 2025, awaiting FDA approval.
Is Research Triangle Park in Raleigh?
Not for Census purposes. Research Triangle Park lies mostly in Durham County, which belongs to the Durham-Chapel Hill metro, while Raleigh's metro is Wake, Johnston and Franklin counties. That's why Census data shows only 86 biotechnology R&D establishments in the Raleigh metro and 100 in Durham's. Morrisville, on the park's edge, sits mostly in Wake County.
How much do pharmaceutical manufacturing jobs pay in Raleigh?
Drug manufacturing establishments in the Raleigh-Cary metro paid $566.9 million to 5,429 employees in 2023, an average of $104,425 a year, according to Census County Business Patterns. That's an average across every job at those sites, from operators to managers. It's lower than Boston's $146,055 but above North Carolina's statewide average of $94,639.